DCLK3 and glioma: Parallel pathways operate through the CGRP/adrenomedullin family: glioma specimens up-regulate adrenomedullin-2, whose ligation of CLR–RAMP2 boosts ERK1/2 activation, enhances filopodia formation and potentiates temozolomide resistance (49).